Fangliang Zhang

Fangliang Zhang

Auto-generated profile, based on publicly available information

Fangliang Zhang

University of Miami

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2016 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
AKAkhilesh Kumar
Akhilesh Kumar
MBMichael D Birnbaum
Michael D Birnbaum
DPDevang Patel
Devang Patel
WMWilliam M Morgan
William M Morgan
JSJayanti Singh
Jayanti Singh
FZFangliang Zhang
Fangliang Zhang
Arginyltransferase 1 (Ate1) mediates protein arginylation, a poorly understood protein posttranslational modification (PTM) in eukaryotic cells. Previous evidence suggest a potential involvement of arginylation in stress response and this PTM was traditionally considered anti-apoptotic based on the studies of individual substrates. However, here we found that arginylation promotes cell death and/or growth arrest, depending on the nature and intensity of the stressing factor. Specifically, in yeast, mouse and human cells, deletion or downregulation of the ATE1 gene disrupts typical stress responses by bypassing growth arrest and suppressing cell death events in the presence of disease-related stressing factors, including oxidative, heat, and osmotic stresses, as well as the exposure to heavy metals or radiation. Conversely, in wild-type cells responding to stress, there is an increase of cellular Ate1 protein level and arginylation activity. Furthermore, the increase of Ate1 protein directly promotes cell death in a manner dependent on its arginylation activity. Finally, we found Ate1 to be required to suppress mutation frequency in yeast and mammalian cells during DNA-damaging conditions such as ultraviolet irradiation. Our study clarifies the role of Ate1/arginylation in stress response and provides a new mechanism to explain the link between Ate1 and a variety of diseases including cancer. This is also the first example that the modulation of the global level of a PTM is capable of affecting DNA mutagenesis.

3 September 2018 in Oncogene
Verified
Journal Article
Closed access
PDF file
MBMichael D. Birnbaum
Michael D. Birnbaum
NZNing Zhao
Ning Zhao
BMBalaji T. Moorthy
Balaji T. Moorthy
DPDevang Patel
Devang Patel
OKOleksandr N. Kryvenko
Oleksandr N. Kryvenko
FZFangliang Zhang
Fangliang Zhang

21 December 2020 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
CJChunhua Jiang
Chunhua Jiang
BMBalaji T. Moorthy
Balaji T. Moorthy
DPDevang M. Patel
Devang M. Patel
AKAkhilesh Kumar
Akhilesh Kumar
WMWilliam M. Morgan
William M. Morgan
FZFangliang Zhang
Fangliang Zhang
Arginyltransferase 1 (ATE1) is an evolutionary-conserved eukaryotic protein that localizes to the cytosol and nucleus. It is the only known enzyme in metazoans and fungi that catalyzes posttranslational arginylation. Lack of arginylation has been linked to an array of human disorders, including cancer, by altering the response to stress and the regulation of metabolism and apoptosis. Although mitochondria play relevant roles in these processes in health and disease, a causal relationship between ATE1 activity and mitochondrial biology has yet to be established. Here, we report a phylogenetic analysis that traces the roots of ATE1 to alpha-proteobacteria, the mitochondrion microbial ancestor. We then demonstrate that a small fraction of ATE1 localizes within mitochondria. Furthermore, the absence of ATE1 influences the levels, organization, and function of respiratory chain complexes in mouse cells. Specifically,ATE1-KO mouse embryonic fibroblasts have increased levels of respiratory supercomplexes I+III2+IVn. However, they have decreased mitochondrial respiration owing to severely lowered complex II levels, which leads to accumulation of succinate and downstream metabolic effects. Taken together, our findings establish a novel pathway for mitochondrial function regulation that might explain ATE1-dependent effects in various disease conditions, including cancer and aging, in which metabolic shifts are part of the pathogenic or deleterious underlying mechanism.

4 March 2022 in Developmental Cell
Verified
Journal Article
Closed access
BMBalaji T. Moorthy
Balaji T. Moorthy
CJChunhua Jiang
Chunhua Jiang
DPDevang M. Patel
Devang M. Patel
YBYuguang Ban
Yuguang Ban
COCorin R. O’SHea
Corin R. O’SHea
FZFangliang Zhang
Fangliang Zhang

1 August 2018 in Cell Chemical Biology
Verified
Journal Article
Closed access
MBMichael D. Birnbaum
Michael D. Birnbaum
LNLeah Nemzow
Leah Nemzow
AKAkhilesh Kumar
Akhilesh Kumar
FGFeng Gong
Feng Gong
FZFangliang Zhang
Fangliang Zhang

24 July 2019 in BMC Genomics
Verified
Journal Article
Open access
PDF file
AKAkhilesh Kumar
Akhilesh Kumar
MBMichael D. Birnbaum
Michael D. Birnbaum
BMBalaji Thas Moorthy
Balaji Thas Moorthy
JSJayanti Singh
Jayanti Singh
APAnna Palovcak
Anna Palovcak
FZFangliang Zhang
Fangliang Zhang
Reporter methods to quantitatively measure the efficiency and specificity of genome editing tools are important for the development of novel editing techniques and successful applications of available ones. However, the existing methods have major limitations in sensitivity, accuracy, and/or readiness for in vivo applications. Here, we aim to develop a straight-forward method by using nucleotide insertion/deletion resulted from genome editing. In this system, a target sequence with frame-shifting length is inserted after the start codon of a cerulean fluorescence protein (CFP) to inactivate its fluorescence. As such, only a new insertion/deletion event in the target sequence will reactivate the fluorescence. This reporter is therefore termed as “Insertion/deletion-activated frame-shift fluorescence protein”. To increase its traceability, an internal ribosome entry site and a red fluorescence protein mCherryFP are placed downstream of the reporter. The percentage of CFP-positive cells can be quantified by fluorescence measuring devices such as flow cytometer as the readout for genome editing frequency. To test the background noise level, sensitivity, and quantitative capacity of this new reporter, we applied this approach to examine the efficiency of genome editing of CRISPR/Cas9 on two different targeting sequences and in three different cell lines, in the presence or absence of guide-RNAs with or without efficiency-compromising mutations. We found that the insertion/deletion-activated frame-shift fluorescence protein has very low background signal, can detect low-efficiency genome editing events driven by mutated guideRNAs, and can quantitatively distinguish genome editing by normal or mutated guideRNA. To further test whether the positive editing event detected by this reporter indeed correspond to genuine insertion/deletion on the genome, we enriched the CFP-positive cells to examine their fluorescence under confocal microscope and to analyze the DNA sequence of the reporter in the genome by Sanger sequencing. We found that the positive events captured by this reporter indeed correlates with genuine DNA insertion/deletion in the expected genome location. The insertion/deletion-activated frame-shift fluorescence protein reporter has very low background, high sensitivity, and is quantitative in nature. It will be able to facilitate the development of new genome editing tools as well as the application of existing tools.